Metraipolis › archive › dc_bb1c92b0932b

CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges — Europe PMC PMID:42199538

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42199538
DOI
10.3389/fmicb.2026.1747931
License (as archived)
solo-consultazione
Archived
2026-11-02T11:29:56.182Z
SHA-256 of the archived text
0933cca17532e41103bc58bd9e80d8687baf52250d95d1402efc040c0cbf0a6c
Stable URL of this page
https://metraipolis.com/documento/dc_bb1c92b0932b

How to cite

CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges — Europe PMC PMID:42199538 — Europe PMC (en), https://europepmc.org/article/MED/42199538 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb1c92b0932b (Metraipolis archive dc_bb1c92b0932b, sha256 0933cca17532e41103bc58bd9e80d8687baf52250d95d1402efc040c0cbf0a6c)
BibTeX
@misc{dcbb1c92b0932b,
  title = {CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges — Europe PMC PMID:42199538},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42199538},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb1c92b0932b; sha256 0933cca17532e41103bc58bd9e80d8687baf52250d95d1402efc040c0cbf0a6c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42199538. Agents can read the archived copy with the MCP tool read_document.